Get access

The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7–9, 2011

Authors

  • Stephen P. Hunger MD,

    Corresponding author
    1. Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado
    2. Children's Hospital Colorado, Aurora, Colorado
    3. Children's Oncology Group, Philadelphia PA
    • Center for Cancer and Blood Disorders, Children's Hospital Colorado, 13123 East 16th Ave. Box B115, Aurora, CO 80045.===

    Search for more papers by this author
  • Andre Baruchel MD,

    1. Department of Pediatric Hematology, AP-HP Hopital Robert Debré and University Paris Diderot, France
    2. French Acute Lymphoblastic Leukemia Study Group, Paris, France
    Search for more papers by this author
  • Andrea Biondi MD,

    1. Pediatric Department, M. Tettamanti Research Center, University of Milano-Bicocca, Monza, M.I. Italy, Italy
    2. Pediatric Department, M. Tettamanti Research Center, University of Milano-Bicocca, Monza, M.I. Italy, Italy
    Search for more papers by this author
  • William E. Evans PharmD,

    1. Associazione Italiana de Ematologica ed Oncologia Pediatrica, Monza, M.I. Italy
    2. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee
    Search for more papers by this author
  • Sima Jeha MD,

    1. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee
    Search for more papers by this author
  • Mignon Loh MD,

    1. Children's Oncology Group, Philadelphia PA
    2. Departments of Oncology and Pathology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee
    Search for more papers by this author
  • Anja Moericke MD,

    1. Department of Pediatrics, University of California at San Francisco, California,
    2. Berlin-Frankfurt-Münster Group, Kiel, Germany
    Search for more papers by this author
  • Rob Pieters MD, PhD,

    1. Erasmus MC-Sophia Children's Hospital Rotterdam, The Netherlands
    2. Dutch Childhood Oncology Group, The Hague, The Netherlands
    Search for more papers by this author
  • Mary V. Relling PharmD,

    1. Associazione Italiana de Ematologica ed Oncologia Pediatrica, Monza, M.I. Italy
    2. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee
    Search for more papers by this author
  • Kjeld Schmiegelow MD,

    1. Pediatric Clinic, the National University Hospital, Copenhagen, Denmark
    2. Nordic Society of Pediatric Hematology and Oncology, Copenhagen, Denmark
    Search for more papers by this author
  • Martin Schrappe MD, PhD,

    1. Department of Pediatrics, University of California at San Francisco, California,
    2. Berlin-Frankfurt-Münster Group, Kiel, Germany
    Search for more papers by this author
  • Lewis B. Silverman MD,

    1. Division of Hematology-Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute/Children's Hospital Boston, Boston, Massachusetts
    Search for more papers by this author
  • Martin Stanulla MD,

    1. Berlin-Frankfurt-Münster Group, Kiel, Germany
    2. Department of Molecular Hematopoiesis, Hannover Medical School, Hannover, Germany
    Search for more papers by this author
  • Maria Grazia Valsecchi PhD,

    1. Pediatric Department, M. Tettamanti Research Center, University of Milano-Bicocca, Monza, M.I. Italy, Italy
    2. Center of Biostatistics for Clinical Epidemiology, Department of Clinical Medicine and Prevention, University of Milan-Bicocca, Monza, Italy
    Search for more papers by this author
  • Ajay Vora MD,

    1. Department of Paediatric Haematology, The Children's Hospital Sheffield, Sheffield, UK
    2. United Kingdom Medical Research Council Acute Lymphoblastic Leukemia Group, University of Birmingham, Birmingham, UK
    Search for more papers by this author
  • Ching-Hon Pui MD

    1. Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee
    Search for more papers by this author

  • Tribute: This was the first meeting that occurred following the untimely death of James Nachman, one of the founders and leaders of this working group. His absence was mourned by participants who remembered his clinical insights and generosity of spirit. He was missed by all.

Abstract

XXX. Pediatr Blood Cancer

Ancillary